Effects of oestrogen on cardiovascular events in postmenopausal women

被引：0
|
作者：
Herrington, DM [1 ]
机构：
[1] Wake Forest Univ, Sch Med, Dept Internal Med Cardiol, Winston Salem, NC 27157 USA
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2001年 / 3卷 / 0M期
关键词：
cardiovascular disease; hormone replacement therapy; oestrogen. primary prevention; secondary prevention;
D O I：
10.1016/S1520-765X(01)90076-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A number of randomized clinical trials have investigated the role of hormone replacement therapy (HRT) in primary and secondary prevention of clinical and anatomical manifestations of atherosclerosis. There is mounting evidence that HRT does not slow the progression of clinical or anatomical manifestations of atherosclerosis in women with established disease. Indeed, there appears to be a pattern of increased risk among new users of HRT. In contrast, there are encouraging new data that suggest that HRT may be more effective in women who have not yet developed clinical manifestations of coronary disease. (C) 2001 The European Society of Cardiology.
引用
收藏
页码：M7 / M11
页数：5
相关论文
共 50 条
  • [1] Vasomotor symptoms and cardiovascular events in postmenopausal women
    Szmuilowicz, Emily D.
    Manson, Joann E.
    Rossouw, Jacques E.
    Howard, Barbara V.
    Margolis, Karen L.
    Greep, Nancy C.
    Brzyski, Robert G.
    Stefanick, Marcia L.
    O'Sullivan, Mary Jo
    Wu, Chunyuan
    Allison, Matthew
    Grobbee, Diederick E.
    Johnson, Karen C.
    Ockene, Judith K.
    Rodriguez, Beatriz L.
    Sarto, Gloria E.
    Vitolins, Mara Z.
    Seely, Ellen W.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (06): : 603 - 610
  • [2] Effects of oestrogen and testosterone therapy on serum metabolites in postmenopausal women
    Zang, Hong
    Moritz, Thomas
    Norstedt, Gunnar
    Hirschberg, Angelica L.
    Tollet-Egnell, Petra
    CLINICAL ENDOCRINOLOGY, 2012, 77 (02) : 288 - 295
  • [3] Safety of vaginal oestrogen in postmenopausal women
    Kalentzi, Theodora
    Panay, Nick
    OBSTETRICIAN & GYNAECOLOGIST, 2005, 7 (04) : 241 - 244
  • [4] Effects of oral estradiol and levonorgestrel on cardiovascular risk markers in postmenopausal women
    Terauchi, Masakazu
    Honjo, Hideo
    Mizunuma, Hideki
    Aso, Takeshi
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (06) : 1647 - 1656
  • [5] Oestrogen therapy for urinary incontinence in postmenopausal women
    Cody, June D.
    Jacobs, Madeleine Louisa
    Richardson, Karen
    Moehrer, Birgit
    Hextall, Andrew
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10):
  • [6] Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women
    Liang, YL
    Teede, H
    Shiel, LM
    Thomas, A
    Craven, R
    Sachithanandan, N
    McNeil, JJ
    Cameron, JD
    Dart, A
    McGrath, BP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (06) : 457 - 459
  • [7] Oestrogen therapy for urinary incontinence in postmenopausal women
    Cody, June D.
    Richardson, Karen
    Moehrer, Birgit
    Hextall, Andrew
    Glazener, Cathryn M. A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [8] Osteoporosis Prevention and Treatment: The Risk of Comorbid Cardiovascular Events in Postmenopausal Women
    Gilbert, Zachary A.
    Muller, Avia
    Leibowitz, Jillian A.
    Kesselman, Marc M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [9] Effects of key physiological parameters on cardiovascular disease and osteoporosis risk in perimenopausal and postmenopausal women
    Mou, Hong
    Zhang, Jun
    Guo, Yichuan
    Xu, Liangzhi
    Luo, Xiaoyan
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women
    Herrington, DM
    Pusser, BE
    Riley, WA
    Thuren, TY
    Brosnihan, KB
    Brinton, EA
    MacLean, DB
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) : 1606 - 1612
12345